Ponoi Management, LLC
Follow13F filer, CIK 1720702, San Francisco, CA
Ponoi Management, LLC reported $63,337,000 across 4 holdings for the quarter ended 2022-06-30, in a 13F-HR filed 2022-08-15.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-22-008911
- Period
- 2022-06-30
- Reported value
- $63.3M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| NRIXadded | +1 | $12 |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q2 2022
Share positions as resolved from 13F-HR 0000950123-22-008911, largest first. % of portfolio is the value over $63,337,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| RAPT THERAPEUTICS INCRAPT THERAPEUTICS INC | 1,599,417 | $29.2M | 46.09% | 0 | |||
| NGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INC | 1,298,908 | $16.7M | 26.29% | 0 | |||
| RVMDREVOLUTION MEDICINES INC | 685,011 | $13.4M | 21.08% | 0 | Timeline | ||
| NRIXNURIX THERAPEUTICS INC | 327,123 | $4.14M | 6.54% | +1 | Timeline |
How Q2 2022 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-22-008911 | base | 2022-08-15 | acceptance time not in the bulk data set |